A Multi-Country Non-Inferiority Cluster Randomized Trial of Frontloaded Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis
Background:
More than 50 million people around the world are investigated for tuberculosis using sputum smear microscopy annually. This process requires repeated visits and patients often drop out.
Methods and Findings:
This clinical trial of adults with cough ≥2 wk duration (in Ethiopia, Nepal, Nigeria, and Yemen) compared the sensitivity/specificity of two sputum samples collected “on the spot” during the first visit plus one sputum sample collected the following morning (spot-spot-morning [SSM]) versus the standard spot-morning-spot (SMS) scheme. Analyses were per protocol analysis (PPA) and intention to treat (ITT). A sub-analysis compared just the first two smears of each scheme, spot-spot and spot-morning.
In total, 6,627 patients (3,052 SSM/3,575 SMS) were enrolled; 6,466 had culture and 1,526 were culture-positive. The sensitivity of SSM (ITT, 70.2%, 95% CI 66.5%–73.9%) was non-inferior to the sensitivity of SMS (PPA, 65.9%, 95% CI 62.3%–69.5%). Similarly, the specificity of SSM (ITT, 96.9%, 95% CI 93.2%–99.9%) was non-inferior to the specificity of SMS (ITT, 97.6%, 95% CI 94.0%–99.9%). The sensitivity of spot-spot (ITT, 63.6%, 95% CI 59.7%–67.5%) was also non-inferior to spot-morning (ITT, 64.8%, 95% CI 61.3%–68.3%), as the difference was within the selected −5% non-inferiority limit (difference ITT = 1.4%, 95% CI −3.7% to 6.6%). Patients screened using the SSM scheme were more likely to provide the first two specimens than patients screened with the SMS scheme (98% versus 94.2%, p<0.01). The PPA and ITT analysis resulted in similar results.
Conclusions:
The sensitivity and specificity of SSM are non-inferior to those of SMS, with a higher proportion of patients submitting specimens. The scheme identifies most smear-positive patients on the first day of consultation.
Trial Registration: Current Controlled Trials ISRCTN53339491
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
A Multi-Country Non-Inferiority Cluster Randomized Trial of Frontloaded Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis. PLoS Med 8(7): e32767. doi:10.1371/journal.pmed.1000443
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000443
Souhrn
Background:
More than 50 million people around the world are investigated for tuberculosis using sputum smear microscopy annually. This process requires repeated visits and patients often drop out.
Methods and Findings:
This clinical trial of adults with cough ≥2 wk duration (in Ethiopia, Nepal, Nigeria, and Yemen) compared the sensitivity/specificity of two sputum samples collected “on the spot” during the first visit plus one sputum sample collected the following morning (spot-spot-morning [SSM]) versus the standard spot-morning-spot (SMS) scheme. Analyses were per protocol analysis (PPA) and intention to treat (ITT). A sub-analysis compared just the first two smears of each scheme, spot-spot and spot-morning.
In total, 6,627 patients (3,052 SSM/3,575 SMS) were enrolled; 6,466 had culture and 1,526 were culture-positive. The sensitivity of SSM (ITT, 70.2%, 95% CI 66.5%–73.9%) was non-inferior to the sensitivity of SMS (PPA, 65.9%, 95% CI 62.3%–69.5%). Similarly, the specificity of SSM (ITT, 96.9%, 95% CI 93.2%–99.9%) was non-inferior to the specificity of SMS (ITT, 97.6%, 95% CI 94.0%–99.9%). The sensitivity of spot-spot (ITT, 63.6%, 95% CI 59.7%–67.5%) was also non-inferior to spot-morning (ITT, 64.8%, 95% CI 61.3%–68.3%), as the difference was within the selected −5% non-inferiority limit (difference ITT = 1.4%, 95% CI −3.7% to 6.6%). Patients screened using the SSM scheme were more likely to provide the first two specimens than patients screened with the SMS scheme (98% versus 94.2%, p<0.01). The PPA and ITT analysis resulted in similar results.
Conclusions:
The sensitivity and specificity of SSM are non-inferior to those of SMS, with a higher proportion of patients submitting specimens. The scheme identifies most smear-positive patients on the first day of consultation.
Trial Registration: Current Controlled Trials ISRCTN53339491
: Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization 2009 Global tuberculosis control: epidemiology, strategy, financing. Geneva World Health Organization
2. PerkinsMD
CunninghamJ
2007 Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196 Suppl 1 S15 S27
3. International Union Against Tuberculosis and Lung Disease 2000 Technical guide. Sputum examination for tuberculosis by direct microscopy in low-income countries Paris International Union Against Tuberculosis and Lung Disease 5th edition
4. World Health Organization 1998 Tuberculosis handbook. Geneva World Health Organization
5. AndrewsRH
RadhakrishnaS
1959 A comparison of two methods of sputum collection in the diagnosis of pulmonary tuberculosis. Tubercle 40 155 162
6. ChandrasekaranV
RamachandranR
CunninghamJ
BalasubramaniunR
ThomasA
2005 Factors leading to tuberculosis diagnostic drop-out and delayed treatment initiation in Chennai, India. Int J Tuberc Lung Dis 9 172
7. KempJ
SquireSB
NyirendaIK
SalaniponiFML
1996 Is tuberculosis diagnosis a barrier to care? Trans R Soc Trop Med Hyg 90 472
8. NotaA
AylesH
PerkinsM
CunninghamJ
2005 Factors leading to tuberculosis diagnostic drop-out and delayed treatment initiation in urban Lusaka. Int J Tuberc Lung Dis 9 305
9. MaseSR
RamsayA
NgV
HenryM
HopewellPC
2007 Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 11 485 495
10. World Health Organization 2007 Definition of a new sputum smear-positive TB case. Geneva World Health Organization
11. World Health Organization 2007 Reduction of number of smears for the diagnosis of pulmonary TB. Geneva World Health Organization
12. RamsayA
YassinMA
CambanisA
HiraoS
AlmotawaA
2009 Front-loading sputum microscopy services: an opportunity to optimise smear-based case-detection of tuberculosis in high prevalence countries. J Trop Med 2009 398767
13. CambanisA
YassinMA
RamsayA
SquireSB
ArbideI
2006 A one-day method for the diagnosis of pulmonary tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis 10 230 232
14. HiraoS
YassinMA
KhamofuHG
LawsonL
CambanisA
2007 Same-day smears in the diagnosis of tuberculosis. Trop Med Int Health 12 1459 1463
15. CambanisA
YassinMA
RamsayA
Bertel SquireS
ArbideI
2005 Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Trop Med Int Health 10 330 335
16. KeelerE
PerkinsMD
SmallP
HansonC
ReedS
2006 Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 Suppl 1 49 57
17. LiuX
ThomsonR
GongY
ZhaoF
SquireSB
2007 How affordable are TB diagnosis and teatment in rural China? An analysis from community and TB patient perspectives. Trop Med Int Health 12 1464 1471
18. CuevasLE
Al-SonboliN
LawsonL
YassinMA
ArbideI
2011 LED Fluorescence Microscopy for the Diagnosis of Pulmonary Tuberculosis: A Multi-Country Cross-Sectional Evaluation. PLoS Med 8 e1057 doi:10.1371/journal.pmed.1001057
19. KhanMS
DarO
SismanidisC
ShahK
Godfrey-FaussettP
2007 Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 369 1955 1960
20. AzizMA
BaF
Becx-BleuminkM
BretzelG
HumesR
2002 External quality assessment for AFB smear microscopy.
RidderhofJ
HumesR
BoulahbalF
Washington (District of Columbia) Association of Public Health Laboratories
21. ReichmanLB
HerschfieldES
2006 Tuberculosis: a comprehensive international approach, 3rd ed. New York Informa Healthcare USA
22. KhanMS
KhanS
Godfrey-FaussetP
2009 Default during TB diagnosis: quantifying the problem. Trop Med Int Health 14 1437 1441
23. BothaE
Den BoonS
VerverS
DunbarR
LawrenceKA
2008 Initial default from tuberculosis treatment: how often does it happen and what are the reasons? Int J Tuberc Lung Dis 12 820 823
24. BothaE
Den BoonS
LawrenceKA
ReuterH
VerverS
2008 From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 12 936 941
25. CreekTL
LockmanS
KenyonTA
MakhoaM
ChimidzaN
2000 Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Kabore, Botswana. Int J Tuberc Lung Dis 4 956 961
26. HarriesAD
RusenID
ChiangCY
HinderakerSG
EnarsonDA
2009 Registering initial defaulters and reporting on their treatment outcomes. Int J Tuberc Lung Dis 13 801 803
27. SquireSB
BelayeAK
KashotiA
SalaniponiFM
MundyCJ
2005 ‘Lost’ smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 9 25 31
28. World Health Organization 2007 New WHO policies. Revised WHO policy guidelines for tuberculosis. Geneva World rganization
29. BoehmeCC
NabetaP
HillemannD
NicolMP
ShenaiS
2010 Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363 1005 1015
30. NunnAJ
PhillipsPP
GillespieSH
2008 Design issues in pivotal drug trials for drug sensitive tuberculosis (TB). Tuberculosis (Edinb) 88 Suppl 1 S85 S92
31. GarattiniS
BerteleV
2007 Non-inferiority trials are unethical because they disregard patients' interests. Lancet 370 1875 1877
32. Van DeunA
ZwahlenM
BolaV
LebekeR
BahatiE
2007 Validation of candidate smear microscopy quality indicators, extracted from tuberculosis laboratory registers. Int J Tuberc Lung Dis 11 300 305
33. EdgintonME
WongML
HodkinsonHJ
2006 Tuberculosis at Chris Hani Baragwanath Hospital: an intervention to improve patient referrals to district clinics. Int J Tuberc Lung Dis 10 1018 1022
34. HouyangH
ChepoteF
GilmanRH
MooreDA
2005 Failure to complete the TB diagnostic algorithm in urban Perú: a study of contributing factors. Trop Doct 35 120 121
35. ThongraungW
ChongsuvivatwongV
PungrassameeP
2008 Multilevel factors affecting tuberculosis diagnosis and initial treatment. J Eval Clin Pract 14 378 384
36. ZhangT
TangS
JunG
WhiteheadM
2007 Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health 7 19
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Individualized Cost-Effectiveness Analysis
- GeneXpert—A Game-Changer for Tuberculosis Control?
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
- Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort